NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

{
  "id": "010544-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-03-21T08:19:24Z",
  "ocid": "ocds-h6vhtk-04f708",
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "tender": {
    "id": "C346388",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2027-05-31T23:59:59+01:00",
          "startDate": "2025-12-01T00:00:00Z",
          "maxExtentDate": "2029-05-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          },
          {
            "id": "33690000",
            "scheme": "CPV",
            "description": "Various medicinal products"
          }
        ]
      }
    ],
    "title": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025",
    "value": {
      "amount": 1516353164,
      "currency": "GBP",
      "amountGross": 1819623796
    },
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye",
    "communication": {
      "futureNoticeDate": "2025-06-02T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PDPT-3135-BWWY",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI45",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "NHS England",
        "email": "b.kullootee@nhs.net"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "010544-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/010544-2025",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2025-03-21T08:19:24Z"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2025-04-11T23:59:59+01:00",
        "description": "NHS England is pleased to invite suppliers to a virtual 1:1 preliminary market engagement meeting in relation to the upcoming re-tender of the Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines Framework. The purpose of the sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, clinical aspects and KPI's. Please contact b.kullootee@nhs.net or michelle.clarke6@nhs.net to register your interest. There will also be a 7 day window for queries to be raised in writing after all sessions have concluded."
      }
    ]
  },
  "initiationType": "tender"
}